What Is the Best Imaging for Staging High-Risk Prostate Cancer?
ACR-guided imaging workflow for Clinically established high-risk prostate cancer. Staging. (Pretreatment Detection, Surveillance, and Staging of Prostate C
ACR-guided imaging workflow for Clinically established high-risk prostate cancer. Staging. (Pretreatment Detection, Surveillance, and Staging of Prostate C
ACR-guided imaging workflow for Clinically established intermediate-risk prostate cancer. Staging or surveillance. (Pretreatment Detection, Surveillance, a
ACR-guided imaging workflow for Clinically established low-risk prostate cancer. Active surveillance. (Pretreatment Detection, Surveillance, and Staging of
ACR-guided imaging workflow for Clinically suspected prostate cancer. Negative TRUS-guided biopsy. Initial diagnosis. Next imaging study. (Pretreatment Det
ACR-guided imaging workflow for Clinically suspected prostate cancer. No prior biopsy (biopsy naïve). Initial diagnosis. Initial imaging. (Pretreatment Det
ACR-guided imaging workflow for Renal cell carcinoma. No contraindication to either iodinated CT contrast or gadolinium-based MR intravenous contrast. Stag
ACR-guided imaging workflow for Microhematuria. No risk factors, or history of recent vigorous exercise, or presence of infection, or viral illness, or pre
ACR-guided imaging workflow for Indeterminate renal mass. Contraindication to both iodinated CT and gadolinium-based MR intravenous contrast. Initial imagi
ACR-guided imaging workflow for Adult. Renal transplant dysfunction. Initial imaging. (Renal Transplant Dysfunction): recommended study, differential, down
ACR-guided imaging workflow for Renal failure. Chronic kidney disease (CKD). Initial imaging. (Renal Failure): recommended study, differential, downstream